KANG [iKang Healthcare] F-1/A: SUBJECT TO COMPLETION, DATED MARCH 25, 2014 PRELIMINARY

[SUBJECT TO COMPLETION, DATED MARCH 25, 2014 PRELIMINARY PROSPECTUS 10,904,846 American Depositary Shares iKang Healthcare Group, Inc. Representing 5,452,423 Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Healthcare Group, Inc. We are offering 7,574,446 ADSs and the selling shareholders identified in this prospectus are offering an additional 3,330,400 ADSs. Each] [SUBSCRIPTION AGREEMENT Agreement This Subscription Agreement (this “ (1) Company iKang Healthcare Group, Inc., a company incorporated in the Cayman Islands (the “ (2) Purchaser Best Investment Corporation, a limited liability company incorporated in the People’s Republic of China (the “ Party Parties The Purchaser and the Company are sometimes herein referred to each as a “ W I T] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated December 4, 2013 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc., its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012]

KANG [iKang Healthcare] F-6: (Original Filing)

[____________________ FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts ___________________ iKang Healthcare Group, Inc. (Exact name of issuer of deposited securities as specified in its charter) n/a Cayman Islands (Jurisdiction of incorporation or organization of issuer) JPMORGAN CHASE BANK, N.A. (Exact name of depositary as specified in its charter) 1] [J.P.Morgan TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1 (e) Deliver, execute, issue et al. 1 (f) Delivery Order 1] [Ziegler, Ziegler & Associates LLP Counselors at Law th 570 Lexington Avenue, 44 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 March 25, 2014 JPMorgan Chase Bank, N.A., as Depositary 1 Chase Manhattan Plaza, Floor 58 New York, New York 10005 American Depositary Shares evidenced by American Depositary Receipts for deposited Class A common shares of iKang Healthcare]

KANG [iKang Healthcare] F-6: ____________________ FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES

[____________________ FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts ___________________ iKang Healthcare Group, Inc. (Exact name of issuer of deposited securities as specified in its charter) n/a Cayman Islands (Jurisdiction of incorporation or organization of issuer) JPMORGAN CHASE BANK, N.A. (Exact name of depositary as specified in its charter) 1] [J.P.Morgan TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1 (e) Deliver, execute, issue et al. 1 (f) Delivery Order 1] [Ziegler, Ziegler & Associates LLP Counselors at Law th 570 Lexington Avenue, 44 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 March 25, 2014 JPMorgan Chase Bank, N.A., as Depositary 1 Chase Manhattan Plaza, Floor 58 New York, New York 10005 American Depositary Shares evidenced by American Depositary Receipts for deposited Class A common shares of iKang Healthcare]

KANG [iKang Healthcare] CORRESP: (Original Filing)

[New York Menlo Park Washington DC São Paulo London Paris Madrid Tokyo Beijing Hong Kong Li He Davis Polk & Wardwell LLP 2201 China World Office 2 1 Jian Guo Men Wai Avenue Chaoyang District Beijing 100004 86 10 8567 5005 tel 86 10 8567 5105 fax li.he@davispolk.com March 21, 2014 iKang Healthcare Group, Inc. Registration Statement on Form F-1]

KANG [iKang Healthcare] CORRESP: New York Menlo Park Washington DC São Paulo

[New York Menlo Park Washington DC São Paulo London Paris Madrid Tokyo Beijing Hong Kong Li He Davis Polk & Wardwell LLP 2201 China World Office 2 1 Jian Guo Men Wai Avenue Chaoyang District Beijing 100004 86 10 8567 5005 tel 86 10 8567 5105 fax li.he@davispolk.com March 21, 2014 iKang Healthcare Group, Inc. Registration Statement on Form F-1]

KANG [iKang Healthcare] F-1/A: (Original Filing)

[SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Healthcare Group, Inc. We are offering ADSs and the selling shareholders identified in this prospectus are offering an additional ADSs. Each ADS represents Class A common] [iKang Healthcare Group, Inc. (a Cayman Islands company) — [ — Each Representing [ — (Par Value US$[ FORM OF UNDERWRITING AGREEMENT [ — ], 2014 Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park New York, New York 10036 UBS Securities LLC 299 Park Avenue New York, New York 10171 as Representatives of the several Underwriters Ladies and] [THE COMPANIES LAW EXEMPTED COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF IKANG HEALTHCARE GROUP, INC. (adopted by way of special resolution passed on 1 March, 2014) 1. iKang Healthcare Group, Inc. The name of the Company is 2. The Registered Office of the Company shall be at the offices of Codan Trust Company (Cayman) Limited, Cricket] [The Companies Law (Revised) Company Limited by Shares THE AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF iKang Healthcare Group, Inc. (Adopted by way of a special resolution passed on March 1, 2014 conditionally upon consummation of the IPO) 1. The name of the Company is iKang Healthcare Group, Inc. 2. The Registered Office of the Company shall be at the] [Incorporated in the Cayman Islands iKang Healthcare Group, Inc. This is to certify that is / are the registered shareholders of: No. of Shares Type of Share Par Value Class A Common Shares USD 0.01 Date of Record Certificate Number % Paid The above shares are subject to the Memorandum and Articles of Association of the Company and transferrable in] [TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions 1 (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1] [SHAREHOLDERS’ AGREEMENT Agreement Company iKang BVI Schedule A Preferred A Holder Schedule B Preferred B Holder Schedule C Preferred C Holder Schedule D-1 Schedule D-2 Preferred D Holder Schedule E Preferred E Holder Preferred F-1 Holder Schedule F Preferred F-2 Holder Preferred F Holders Schedule G Common A Holder Schedule H Common B Holder THIS SHAREHOLDERS’ AGREEMENT (this “ RECITALS] [AMENDMENT NO.1 TO SHAREHOLDERS’ AGREEMENT Amendment Company iKang BVI Schedules A, B, C, D-1, D-2 , E, F, G and H Existing Holders THIS AMENDMENT NO. 1 TO SHAREHOLDERS’ AGREEMENT (this “ RECITALS A. Shareholders’ Agreement The Company, iKang BVI, the Company Group Holdcos, the Founders and the Existing Holders entered into a Shareholders’ Agreement dated as of March 1,] [Dated the day of March 1, 2014 THE PERSONS NAMED IN SCHEDULE 1 (as the “Transferors”) and IKANG HEALTHCARE GROUP, INC. (as the “Company”) and IKANG GUOBIN HEALTHCARE GROUP, INC. SHARE SWAP AGREEMENT 1 THIS AGREEMENT is made the day of March 1, 2014 BETWEEN: (1) Transferor Transferors The persons whose names and addresses are set out in the first] [Option Award Arrangement Agreement This Option Award Arrangement Agreement (the “Agreement”), dated as of December 30, 2013, is entered into in Shanghai between: Qian Hui, PRC ID No. 340102196811301522; iKang Guobin Healthcare Group, Inc., a limited company incorporated under the laws of the British Virgin Islands whose registered address is Palm Grove House, P.O. Box 3186, Wickhams Cay I, Road] [19 March 2014 iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China OUR REF: AC/al/#5983081(M#894889) Dear Sirs, iKang Healthcare Group, Inc. (the “Company”) Commission Registration Statement Securities Act Common Shares For the purposes of giving this opinion, we have examined a copy of the Registration Statement. We have also reviewed the] [19 March 2014 Matter No.:894889 Doc Ref: AC/al/#5983285 iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Dear Sirs, iKang Healthcare Group, Inc. he “Company”) Commission Registration Statement Securities Act Common Shares For the purposes of giving this opinion, we have examined and relied upon copies of the following documents: (i)] [March 21, 2014 iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China We have examined such matters of fact and law as we have deemed necessary or advisable for the purpose of our opinion. We hereby confirm that our opinion as to the material U.S. federal income tax consequences to “U.S.] [IKANG HEALTHCARE GROUP, INC. SHARE INCENTIVE PLAN (effective as of February 26, 2013 and as subsequently amended) Section 1 The purpose of the iKang Healthcare Group, Inc. Share Incentive Plan is to enhance the ability of iKang Healthcare Group, Inc. to attract and retain exceptionally qualified individuals and to encourage them to acquire a proprietary interest in the growth and] [IKANG HEALTHCARE GROUP, INC. SHARE INCENTIVE PLAN (effective as of April 28, 2013 and as subsequently amended) Section 1 The purpose of the iKang Healthcare Group, Inc. Share Incentive Plan is to enhance the ability of iKang Healthcare Group, Inc. to attract and retain exceptionally qualified individuals and to encourage them to acquire a proprietary interest in the growth and] [IKANG HEALTHCARE GROUP, INC. 2014 SHARE INCENTIVE PLAN Section 1 The purpose of the iKang Healthcare Group, Inc. Share Incentive Plan is to enhance the ability of iKang Healthcare Group, Inc. to attract and retain exceptionally qualified individuals and to encourage them to acquire a proprietary interest in the growth and performance of the Company. Section 2 Definitions As used] [FORM OF INDEMNIFICATION AGREEMENT IKANG HEALTHCARE GROUP, INC. Agreement Company Indemnitee This Indemnification Agreement (this “ W I T N E S S E T H: WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors or executive officers unless they are provided with adequate protection through insurance or adequate indemnification against risks of claims and] [EMPLOYMENT AGREEMENT Agreement This Employment Agreement (the “ WHEREAS, the Company and Executive wish to enter into an employment agreement whereby the Executive will be employed by the Company in accordance with the terms and conditions stated below; NOW, THEREFORE, the parties hereby agree as follows: ARTICLE 1 MPLOYMENT UTIES ND ESPONSIBILITIES E . Employment. Section 1.01 . Duties and] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated December 4, 2013 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc., its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012] [IKANG HEALTHCARE GROUP, INC. Code of Business Conduct and Ethics Adopted March 21, 2014 Introduction Code This Code of Business Conduct and Ethics (the “ We must strive to foster a culture of honesty and accountability. Our commitment to the highest level of ethical conduct should be reflected in all of the Company’s business activities, including, but not limited to,] [Form of PRC Legal Opinion [ — ] To: iKang Guobin Healthcare Group, Inc. (the “Company”) B-6F, Shimao Tower 92A Jianguo Road, Chaoyang District Beijing 100022, People’s Republic of China Re: Legal Opinion PRC We are qualified lawyers of the People’s Republic of China (the “ Offering ADSs Registration Statement Commission We have acted as PRC counsel for the Company]

KANG [iKang Healthcare] F-1/A: SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS

[SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Healthcare Group, Inc. We are offering ADSs and the selling shareholders identified in this prospectus are offering an additional ADSs. Each ADS represents Class A common] [iKang Healthcare Group, Inc. (a Cayman Islands company) — [ — Each Representing [ — (Par Value US$[ FORM OF UNDERWRITING AGREEMENT [ — ], 2014 Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park New York, New York 10036 UBS Securities LLC 299 Park Avenue New York, New York 10171 as Representatives of the several Underwriters Ladies and] [THE COMPANIES LAW EXEMPTED COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF IKANG HEALTHCARE GROUP, INC. (adopted by way of special resolution passed on 1 March, 2014) 1. iKang Healthcare Group, Inc. The name of the Company is 2. The Registered Office of the Company shall be at the offices of Codan Trust Company (Cayman) Limited, Cricket] [The Companies Law (Revised) Company Limited by Shares THE AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF iKang Healthcare Group, Inc. (Adopted by way of a special resolution passed on March 1, 2014 conditionally upon consummation of the IPO) 1. The name of the Company is iKang Healthcare Group, Inc. 2. The Registered Office of the Company shall be at the] [Incorporated in the Cayman Islands iKang Healthcare Group, Inc. This is to certify that is / are the registered shareholders of: No. of Shares Type of Share Par Value Class A Common Shares USD 0.01 Date of Record Certificate Number % Paid The above shares are subject to the Memorandum and Articles of Association of the Company and transferrable in] [TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions 1 (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1] [SHAREHOLDERS’ AGREEMENT Agreement Company iKang BVI Schedule A Preferred A Holder Schedule B Preferred B Holder Schedule C Preferred C Holder Schedule D-1 Schedule D-2 Preferred D Holder Schedule E Preferred E Holder Preferred F-1 Holder Schedule F Preferred F-2 Holder Preferred F Holders Schedule G Common A Holder Schedule H Common B Holder THIS SHAREHOLDERS’ AGREEMENT (this “ RECITALS] [AMENDMENT NO.1 TO SHAREHOLDERS’ AGREEMENT Amendment Company iKang BVI Schedules A, B, C, D-1, D-2 , E, F, G and H Existing Holders THIS AMENDMENT NO. 1 TO SHAREHOLDERS’ AGREEMENT (this “ RECITALS A. Shareholders’ Agreement The Company, iKang BVI, the Company Group Holdcos, the Founders and the Existing Holders entered into a Shareholders’ Agreement dated as of March 1,] [Dated the day of March 1, 2014 THE PERSONS NAMED IN SCHEDULE 1 (as the “Transferors”) and IKANG HEALTHCARE GROUP, INC. (as the “Company”) and IKANG GUOBIN HEALTHCARE GROUP, INC. SHARE SWAP AGREEMENT 1 THIS AGREEMENT is made the day of March 1, 2014 BETWEEN: (1) Transferor Transferors The persons whose names and addresses are set out in the first] [Option Award Arrangement Agreement This Option Award Arrangement Agreement (the “Agreement”), dated as of December 30, 2013, is entered into in Shanghai between: Qian Hui, PRC ID No. 340102196811301522; iKang Guobin Healthcare Group, Inc., a limited company incorporated under the laws of the British Virgin Islands whose registered address is Palm Grove House, P.O. Box 3186, Wickhams Cay I, Road] [19 March 2014 iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China OUR REF: AC/al/#5983081(M#894889) Dear Sirs, iKang Healthcare Group, Inc. (the “Company”) Commission Registration Statement Securities Act Common Shares For the purposes of giving this opinion, we have examined a copy of the Registration Statement. We have also reviewed the] [19 March 2014 Matter No.:894889 Doc Ref: AC/al/#5983285 iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Dear Sirs, iKang Healthcare Group, Inc. he “Company”) Commission Registration Statement Securities Act Common Shares For the purposes of giving this opinion, we have examined and relied upon copies of the following documents: (i)] [March 21, 2014 iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China We have examined such matters of fact and law as we have deemed necessary or advisable for the purpose of our opinion. We hereby confirm that our opinion as to the material U.S. federal income tax consequences to “U.S.] [IKANG HEALTHCARE GROUP, INC. SHARE INCENTIVE PLAN (effective as of February 26, 2013 and as subsequently amended) Section 1 The purpose of the iKang Healthcare Group, Inc. Share Incentive Plan is to enhance the ability of iKang Healthcare Group, Inc. to attract and retain exceptionally qualified individuals and to encourage them to acquire a proprietary interest in the growth and] [IKANG HEALTHCARE GROUP, INC. SHARE INCENTIVE PLAN (effective as of April 28, 2013 and as subsequently amended) Section 1 The purpose of the iKang Healthcare Group, Inc. Share Incentive Plan is to enhance the ability of iKang Healthcare Group, Inc. to attract and retain exceptionally qualified individuals and to encourage them to acquire a proprietary interest in the growth and] [IKANG HEALTHCARE GROUP, INC. 2014 SHARE INCENTIVE PLAN Section 1 The purpose of the iKang Healthcare Group, Inc. Share Incentive Plan is to enhance the ability of iKang Healthcare Group, Inc. to attract and retain exceptionally qualified individuals and to encourage them to acquire a proprietary interest in the growth and performance of the Company. Section 2 Definitions As used] [FORM OF INDEMNIFICATION AGREEMENT IKANG HEALTHCARE GROUP, INC. Agreement Company Indemnitee This Indemnification Agreement (this “ W I T N E S S E T H: WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors or executive officers unless they are provided with adequate protection through insurance or adequate indemnification against risks of claims and] [EMPLOYMENT AGREEMENT Agreement This Employment Agreement (the “ WHEREAS, the Company and Executive wish to enter into an employment agreement whereby the Executive will be employed by the Company in accordance with the terms and conditions stated below; NOW, THEREFORE, the parties hereby agree as follows: ARTICLE 1 MPLOYMENT UTIES ND ESPONSIBILITIES E . Employment. Section 1.01 . Duties and] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated December 4, 2013 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc., its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012] [IKANG HEALTHCARE GROUP, INC. Code of Business Conduct and Ethics Adopted March 21, 2014 Introduction Code This Code of Business Conduct and Ethics (the “ We must strive to foster a culture of honesty and accountability. Our commitment to the highest level of ethical conduct should be reflected in all of the Company’s business activities, including, but not limited to,] [Form of PRC Legal Opinion [ — ] To: iKang Guobin Healthcare Group, Inc. (the “Company”) B-6F, Shimao Tower 92A Jianguo Road, Chaoyang District Beijing 100022, People’s Republic of China Re: Legal Opinion PRC We are qualified lawyers of the People’s Republic of China (the “ Offering ADSs Registration Statement Commission We have acted as PRC counsel for the Company]

KANG [iKang Healthcare] F-1: (Original Filing)

[SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Healthcare Group, Inc. We are offering ADSs. Each ADS represents Class A common shares, par value US$0.01 per share, of iKang Healthcare Group, Inc. Prior to] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: ShanghaiMed iKang, Inc. Address: Room 610, Building No. 1, KunTai International Mansion, B12 Chaoyang Men Wai Street, Beijing Party B: Shanghai Guobin Medical Holding Co., Ltd. Address: 15/F, Qianjiang Building, 971 Dongfang Road, Pudong New District, Shanghai Party Parties Party A and Party B] [Equity Pledge Agreement Agreement This Equity Pledge Agreement (the Party A: Pledgee ShanghaiMed iKang, Inc. (the “ Address: 7 th Floor, Haorun Mansion, No. 50, Dengshikou Street, Dongcheng District, Beijing Party B: Pledgor He Boquan (the “ ID No.: 442000601107545 Address: No. 01-02, th Floor, Building A1, Zhong Hai Jin Yuan, Binjiang East Road 957, Guangzhou Pledgor Zhang Ligang (the] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC March 17th, 2008 Party A: ShanghaiMed iKang, Inc., a wholly foreign-owned enterprise duly organized and validly existing under the laws of China, with its address at 7 th Floor, Haorun Mansion, No. 50, Dengshikou Street, Dongcheng District, Beijing; Party B: No. 01-02, He Boquan, with the Chinese Identification No.] [Power of Attorney No. 01-02, I, He Boquan, with the Identification Card No. 442000601107545 and the address at th Floor, Building A1, Zhong Hai Jin Yuan, Binjiang East Road 957, Guangzhou, being a shareholder of 50% of the equity (“My Equity”) of Shanghai iKang Guobin Group Co., Ltd., (with the former name of “Shanghai Guobin Medical Holding Co., Ltd.”) hereby] [Power of Attorney I, Zhang Ligang, with the Identification Card No. 110105197103200895 and the address at Room 1010, Building 2, Sunshine 100 International Apartment, No. 2 Guanghua Road, Chaoyang District, Beijing, being a shareholder of 50% of the equity (“My Equity”) of Shanghai iKang Guobin Group Co., Ltd., (with the former name of “Shanghai Guobin Medical Holding Co., Ltd.”) hereby] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Zhejiang iKang Co., Ltd. Address: 1-3 Party B: Hangzhou iKang Guobin Clinic Co., Ltd. Address: 1-3 Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in the PRC of] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee Zhejiang iKang Co., Ltd. (the “ 1-3 Party B: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai Shanghai Yalong Daoyi Services Co., Ltd. Address: Room 105, Building No. 5, Dongding Plaza, No. 1313, Xizang South Road, Shanghai Pledgors (Shanghai iKang Guobin Holding] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: 1-3 Zhejiang iKang Co., Ltd. (WFOE) a wholly-owned subsidiary of a foreign enterprise registered in the British Virgin Islands, with its address at Party B: Shanghai iKang Guobin Holding Co., Ltd., a limited liability company duly organized and validly existing under the laws of the PRC, with] [Power of Attorney Our company, Shanghai iKang Guobin Holding Co., Ltd., with the registered address at Room 3182, No. 2123, Pudong Avenue, Shanghai, being a shareholder of 80% of the equity (“Company Equity”) of Hangzhou iKang Guobin Clinic Co., Ltd., hereby irrevocably authorize Zhejiang iKang Co., Ltd. to exercise the following rights with respect to Company Equity within the term] [Power of Attorney Our company, Shanghai Yalong Daoyi Services Co., Ltd., with the registered address at Room 105, Building No. 5, Dongding Plaza, No. 1313, Xizang South Road, Shanghai, being a shareholder of 20% of the equity (“Company Equity”) of Hangzhou iKang Guobin Clinic Co., Ltd., hereby irrevocably authorize Zhejiang iKang Co., Ltd. to exercise the following rights with respect] [Equity Transfer Contract “Contract” This Equity Transfer Contract (the The Transferor: He Boquan ID No.: 440620196011075452 Address: No. 18, Lane 1, Yinglong Street, Xiaolan Town, Zhongshan City, Guangdong Province The Transferee: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai WHEREAS: “Guobin Healthcare Center” 1. Shanghai Guobin Healthcare Center Co., Ltd. ( 2. The Transferor] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. Address: 75 Wanping South Road, Room 1801, Shanghai. Party B: Shanghai Yuanhua Information Technology Co., Ltd. Address: 397 Jiaozhou Road, Building 5 Room F206, Jingan District, Shanghai. Party Parties Party A and Party B are hereinafter individually] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. (the “ Address: 75 Wanping South Road, Room 1801, Shanghai Party B: Hu Haiqing Address: 8 Chaoyangmen North Street, Dongcheng District, Beijing Zhao Lei Address: 519 Xinhua Road, Room 28B, Changning District, Shanghai Pledgors (Hu Haiqing and Zhao Lei are collectively] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd., a wholly-owned Chinese subsidiary of a enterprise registered in Hong Kong; Party B: Hu Haiqing, whose ID number is 320102198102151619, with his address at 8 Chaoyangmen North Street, Dongcheng District, Beijing; Zhao Lei, whose ID number is 310107196601301213, with his] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Shanghai Yuanhua Information Technology Co., Ltd., hereby irrevocably authorize Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: Yuanhua Medical Consultancy Services] [Power of Attorney I, Zhao Lei, with ID number of 310107196601301213, being a shareholder of 20% of the equity (“My Equity”) of Shanghai Yuanhua Information Technology Co., Ltd., hereby irrevocably authorize Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: Yuanhua Medical Consultancy Services] [Spousal Consent Letter To: ShanghaiMed iKang, Inc I, Baoming Li (ID No. 440620196107155453), legal spouse of Boquan He (ID No. 442000601107545), have acknowledged and carefully read the following agreements signed by Boquan He: Loan Agreement (signed on Jan.12, 2011); Exclusive Call Option Agreement (signed on Mar. 17, 2008); Exclusive Business Cooperation Agreement (signed on Apr. 27, 2007); Power of Attorney] [Spousal Consent Letter To: ShanghaiMed iKang, Inc I, Feiyan Huang (ID No. 110108197010310023), legal spouse of Ligang Zhang (ID No. 110105197103200895), have acknowledged and carefully read the following agreements signed by Ligang Zhang: Loan Agreement (signed on Jan.12, 2011); Exclusive Call Option Agreement (signed on Mar. 17, 2008); Exclusive Business Cooperation Agreement (signed on Apr. 27, 2007); Power of Attorney] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Address: th 701, 7 Party B: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in] [Equity Pledge Agreement Agreement This Equity Pledge Agreement (the “ Party A: Pledgee ShanghaiMed iKang, Inc. (the “ Address: th st 701, 7 Party B: Hu Haiqing (the “Pledgor”) ID Number: 320102198102151619 Party C: Jiandatong Health Technology (Beijing) Co., Ltd. Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. the Party the Parties For the purpose] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Party B: Party C: Party Parties In this Agreement, Party A, Party B and Party C are referred to as a “ WHEREAS: Party B, Hu Haiqing holds 80% of the equity interest in Party C on behalf of Party A; Party A regularly provides Party C] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Jiandatong Health Technology (Beijing) Co., Ltd., hereby irrevocably authorize ShanghaiMed iKang, Inc. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: ShanghaiMed iKang, Inc. is hereby authorized to act] [Statement and Acknowledgment I, as the shareholder of the 20% equity interest in Jiandatong Health Technology (Beijing) Co., Ltd. (hereinafter referred to as “Company”), hereby state and acknowledge that, in the event that Mr. Hu Haiqing transfers, in whole or in part, the 80% equity interest in the Company held by him to any third party, I agree to such] [Subsidiaries Place of Incorporation 1. iKang Guobin Healthcare Group, Inc. British Virgin Islands 2. Bayley & Jackson (China) Medical Services Limited Hong Kong 3. iKang Zhejiang, Inc. British Virgin Islands 4. Yuanhua Healthcare Limited Hong Kong 5. ShanghaiMed iKang, Inc. People’s Republic of China 6. Shanghai iKang Co., Ltd. People’s Republic of China 7. iKang Health Management (Zhejiang) Co., Ltd.] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated December 4, 2013 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc., its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012] [Form of PRC Legal Opinion [ — ] To: iKang Guobin Healthcare Group, Inc. (the “Company”) B-6F, Shimao Tower 92A Jianguo Road, Chaoyang District Beijing 100022, People’s Republic of China Re: Legal Opinion PRC We are qualified lawyers of the People’s Republic of China (the “ Offering ADSs Registration Statement Commission We have acted as PRC counsel for the Company] [February 27, 2014 iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Consent of Frost & Sullivan “Registration Statement” “Company” “SEC” SEC Filings “Report” Frost & Sullivan hereby consents to references to its name in the Registration Statement on Form F-1 (together with any amendments thereto, the Frost & Sullivan (Beijing)]

Skip to toolbar